Fuji Pharma
A pharmaceutical company mainly engaged in the manufacture and sale of prescription based pharmaceutical products.
Launch date
Employees
Market cap
AUD358m
Enterprise valuation
AUD667m (Public information from Sep 2024)
Share price
JPY1263 4554.T
Tokyo Japan (HQ)
Financials
Estimates*
| JPY | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 33.8b | 34.0b | 35.4b | 40.9b | 46.2b | 50.8b | 55.9b |
| % growth | - | 1 % | 4 % | 15 % | 13 % | 10 % | 10 % |
| EBITDA | 5.1b | 5.4b | 6.8b | 7.3b | 7.2b | 8.4b | 9.0b |
| % EBITDA margin | 15 % | 16 % | 19 % | 18 % | 16 % | 17 % | 16 % |
| Profit | 2.1b | 2.4b | 2.7b | 3.4b | 5.8b | 3.9b | 4.2b |
| % profit margin | 6 % | 7 % | 8 % | 8 % | 13 % | 8 % | 8 % |
| EV / revenue | 1.1x | 1.1x | 1.3x | 1.3x | 1.3x | 1.1x | 1.0x |
| EV / EBITDA | 7.4x | 6.8x | 6.8x | 7.5x | 8.1x | 6.9x | 6.3x |
| R&D budget | 3.1b | 2.4b | 2.5b | 3.2b | - | - | - |
| R&D % of revenue | 9 % | 7 % | 7 % | 8 % | - | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | N/A | IPO | |
| Total Funding | - | ||
Related Content
Recent News about Fuji Pharma
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
